Kumar, R.; Singh, S. K.; Singh, S.; Kumar , A. Addressing Cardio-Metabolic Risks in Type 2 Diabetes: Evidence-Based Insights on Efpeglenatide. Int J Basic Clin Pharmacol 2025, 14, 565-582.